The use of CRISPR/Cas9 technology in the study of chronic lymphocytic leukemia.
Authors | |
---|---|
Year of publication | 2020 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Related projects: |
Authors | |
---|---|
Year of publication | 2020 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Related projects: |